KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Costar (CSGP) EBT (2016 - 2025)

Costar (CSGP) has disclosed EBT for 15 consecutive years, with $60.9 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT fell 28.27% to $60.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $30.0 million, a 85.71% decrease, with the full-year FY2025 number at $30.0 million, down 85.71% from a year prior.
  • EBT was $60.9 million for Q4 2025 at Costar, up from -$45.8 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $159.6 million in Q4 2022 to a low of -$45.8 million in Q3 2025.
  • A 5-year average of $81.6 million and a median of $93.6 million in 2021 define the central range for EBT.
  • Peak YoY movement for EBT: surged 187.25% in 2021, then crashed 158.94% in 2025.
  • Costar's EBT stood at $133.4 million in 2021, then grew by 19.62% to $159.6 million in 2022, then dropped by 16.34% to $133.5 million in 2023, then plummeted by 36.41% to $84.9 million in 2024, then fell by 28.27% to $60.9 million in 2025.
  • Per Business Quant, the three most recent readings for CSGP's EBT are $60.9 million (Q4 2025), -$45.8 million (Q3 2025), and $21.6 million (Q2 2025).